NEW YORK (Reuters Health) – After 20 weeks of use, laropiprant continues to reduce flushing related to niacin treatment for a further 12 weeks, according to a study…
NEW YORK (Reuters Health) – Patients with sterile urine before undergoing shock wave lithotripsy can forgo antibiotic prophylaxis, according to the results of a meta-analysis reported in the…
NEW YORK (Reuters Health) – Rather than a 24-hour urine collection to measure proteinuria, a 12-hour urine protein determination and the protein:creatinine ratio can be used for evaluating…
NEW YORK (Reuters Health) – When ventilator-associated pneumonia (VAP) is suspected, the absence of Gram staining on a respiratory specimen reliably rules out the diagnosis. On the other…
NEW YORK (Reuters Health) – Sialendoscopy is safe and effective for the treatment of obstructive diseases of the salivary glands in adults, according results of a systematic review…
NEW YORK (Reuters Health) – Patients with inflammatory joint disease (IJD), including rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis, respond as well to statin therapy as those without…
NEW YORK (Reuters Health) – Smoke from organic matter used as fuel – known as biomass smoke — worsens lung function in young adults, researchers from UK report…
NEW YORK (Reuters Health) – The interferon-gamma release assay (IGRA) is more specific, at least as sensitive, and may better predict disease progression than the tuberculin skin test…
NEW YORK (Reuters Health) – In a phase three study of elderly patients with newly diagnosed acute myeloid leukemia (AML), decitabine achieved a higher response rate, with a…
NEW YORK (Reuters Health) – Blood from patients with uncomplicated hemochromatosis is safe and effective for transfusion, researchers from the Belgian Red Cross report in the June 1st…
